Why Iovance?

Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) cell therapies for people with cancer. We are pioneering a transformational approach to treating cancer by harnessing the ability of the human immune system to recognize and attack diverse cancer cells in each patient. We are committed to continuous innovation in cell therapy, including gene-edited cell therapy, that may extend and improve life for people with cancer.

Our benefits

Health & wellness

  • Flexible medical plans at low or no employee cost
  • Company contributions to Health Savings Accounts
  • Comprehensive dental and vision coverage
  • Flexible Spending and Health Savings Accounts
  • Paid holidays and vacation and sick time
  • Paid parental leave
  • Employee Assistance Program
  • Wellness program (discounts for gym memberships and other wellness activities)

Total rewards

  • Competitive salaries, annual cash bonuses, and long-term incentives
  • 401(k) Plan with match, Traditional and Roth 401(k) options, after-tax feature with in-plan Roth conversions
  • Company paid income protection plans (life, AD&D, short- and long-term disability)
  • Voluntary life insurance available
  • Employee Stock Purchase Plan
  • Professional development opportunities (including tuition assistance program)
  • Legal and Identity Theft Insurance
  • Performance based recognition
  • Stipend for technology and remote work
View Current Opportunities

TIL therapy is an investigational therapy and has not been approved for any indication by the Food and Drug Administration (FDA) or any other regulatory agency. The safety and efficacy of this therapy have not been determined.